The analysis of longitudinal quality of life measures with informative drop-out: a pattern mixture approach

Qual Life Res. 2010 Feb;19(1):137-48. doi: 10.1007/s11136-009-9564-1. Epub 2009 Dec 30.

Abstract

Purpose: The analysis of longitudinal health-related quality of life measures (HRQOL) can be seriously hampered due to informative drop-out. Random effects models assume Missing At Random and do not take into account informative drop-out. We therefore aim to correct the bias due to informative drop-out.

Methods: Analyses of data from a trial comparing standard-dose and high-dose chemotherapy for patients with breast cancer with respect to long-term impact on HRQOL will serve as illustration. The subscale Physical Function (PF) of the SF36 will be used. A pattern mixture approach is proposed to account for informative drop-out. Patterns are defined based on events related to HRQOL, such as death and relapse. The results of this pattern mixture approach are compared to the results of the commonly used random effects model.

Results: The findings of the pattern mixture approach are well interpretable, and different courses over time in different patterns are distinguished. In terms of estimated differences between standard dose and high dose, the results of both approaches are slightly different, but have no consequences for the clinical evaluation of both doses.

Conclusion: Under the assumption that drop-out is at random within the patterns, the pattern mixture approach adjusts the estimates to a certain degree. This approach accounts in a relatively simple way for informative drop-out.

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / epidemiology*
  • Female
  • Humans
  • Likelihood Functions
  • Longitudinal Studies
  • Middle Aged
  • Models, Statistical
  • Netherlands / epidemiology
  • Patient Dropouts / statistics & numerical data*
  • Quality of Life*
  • Randomized Controlled Trials as Topic
  • Statistics as Topic / methods*
  • Survival Analysis

Substances

  • Antineoplastic Agents